UK Report Casts Doubt on £90,000 Alzheimer's Breakthrough
The UK’s National Health Service (NHS) has raised concerns over a £90,000 Alzheimer’s drug, with a recent report suggesting the treatment may offer minimal benefits to patients. The findings, publi…
